Evidence map›Paper›PMID 18479348›Full record

ArticleImmunology2008

Small changes in lymphocyte development and activation in mice through tissue-specific alteration of heparan sulphate.

Omai B Garner, Yu Yamaguchi, Jeffrey D Esko, Vibeke Videm

Open access · greenAbstract read
In one paragraph

Article in Immunology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 39 citations in OpenAlex.

  1. Heparan Sulfate Proteoglycans in Immunity.Proteoglycan research · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Impact of the gut microbiota on enhancer accessibility in gut intraepithelial lymphocytes.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  9. Article
  10. Synthetic di-sulfated iduronic acid attenuates asthmatic response by blocking T-cell recruitment to inflammatory sites.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  11. Review
  12. Article
  13. The glomerular basement membrane as a model system to study the bioactivity of heparan sulfate glycosaminoglycans.Microscopy and microanalysis : the official journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada · 2012
    Review
  14. Article
  15. Heparan sulfate proteoglycans.Cold Spring Harbor perspectives in biology · 2011
    Review
  16. Article
  17. Article
  18. Proteoglycomics: recent progress and future challenges.Omics : a journal of integrative biology · 2010
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Omai B GarnerBiomedical Sciences Graduate Program, University of California, San Diego, La Jolla, CA, USA.
Yu Yamaguchi
Jeffrey D Esko
Vibeke Videm
University of California, San Diego · USNorwegian University of Science and Technology · NOSanford Burnham Prebys Medical Discovery Institute · US

Funding

Siglec Modulation of Inflammation in Humans and MiceP01HL057345 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ESKO, JEFFREY D · 1997 to 2012
$24.1M
Heparan sulfate in neural developmentR01NS049641 · NINDS · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI YAMAGUCHI, YU · 2004 to 2007
$1.7M
Minority Predoctoral Fellowship ProgramF31AI058916 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GARNER, OMAI B · 2004 to 2007
$120k
NHLBI NIH HHS HL57345NHLBI NIH HHS P01 HL057345NIAID NIH HHS AI58916NIAID NIH HHS F31 AI058916NINDS NIH HHS NS49641NINDS NIH HHS R01 NS049641
6 · The paper itself

Abstract

We have examined the role of heparan sulphate in lymphocyte development and activation in mice by conditionally deleting the genes encoding the heparan sulphate biosynthetic enzymes N-deacetylase/N-sulphotransferase-1 and -2 (Ndst1 and Ndst2) and glucuronic acid/N-acetylglucosamine co-polymerase-1 (Ext1) in T cells and B cells, respectively. Ndst1 and Ndst2 are the only Ndst isoforms in T cells. In T-cell Ndst-deficient mice there were normal ratios of CD4(+)/CD8(+) cells in the blood, spleen and thymus, indicating no dramatic effect on development. However, Ndst-deficient T cells were hyperresponsive to low-level activation, suggesting that cell surface heparan sulphate plays a role in T-cell proliferation. The hyperresponsive state correlated with a decrease in cell surface heparan sulphate that occurs in response to activation in wild-type cells. There was a slight change in the number of developing B cells in B-cell Ext1-deficient mice, but the alteration did not cause a change in antibody production. These findings demonstrate that cell surface heparan sulphate may not play a crucial role in lymphocyte development, but can modulate the sensitivity of T cells to activation.

Indexed as

AnimalsCD4-CD8 RatioCell ProliferationCells, CulturedExostosin 1GenotypeHeparan SulfateLymphocyte ActivationLymphocyte SubsetsMiceMice, Inbred C57BLN-AcetylglucosaminyltransferasesSpleenSulfotransferasesThymus GlandT-Lymphocyte SubsetsExostosin 1Heparan Sulfateheparitin sulfotransferaseN-AcetylglucosaminyltransferasesSulfotransferases

Identifiers

PMID18479348
PMCPMC2669145
OpenAlexW2111912987

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.